Cytek Biosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cytek Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CTKB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001831915
Board of directors
-
Deborah J. Neff · DirectorSince 2023
-
Don M. Hardison · DirectorSince 2023
-
Gisele Dion · DirectorSince 2023
-
Glenn P. Muir · DirectorSince 2026
-
Jack Ball · DirectorSince 2023
-
Michael Holder · DirectorSince 2024
-
Ming Yan · Director · CHIEF TECHNOLOGY OFFICERSince 2023
-
Richard Chin · DirectorSince 2025
-
Vera Imper · DirectorSince 2023
-
Wenbin Jiang · Director · PRESIDENT AND CEOSince 2023
Chief executives
Wenbin Jiang
· PRESIDENT AND CEO
Dates unknown
Board connections
4 of this board's directors also sit on 4 other boards.
- via Don M. Hardison and Michael Holder
- via Gisele Dion
- via Glenn P. Muir
- via Glenn P. Muir
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Richard Chin Director | Option exercise | +6,107 | — | — |
| Aug 18, 2026 | Glenn P. Muir Director | Option exercise | +3,086 | — | — |
| Aug 18, 2026 | Michael Holder Director | Option exercise | +2,181 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Option exercise | +11,781 | — | — |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Option exercise | +7,363 | — | — |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Option exercise | +6,320 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −2,869 | $4.67 | $13,398 |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Shares withheld for tax | −1,778 | $4.67 | $8,303 |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Shares withheld for tax | −2,111 | $4.67 | $9,858 |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Option exercise | +22,100 | — | — |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Option exercise | +5,525 | — | — |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Option exercise | +13,051 | — | — |
| Aug 18, 2026 | Wenbin Jiang Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −5,382 | $4.67 | $25,134 |
| Aug 18, 2026 | Ming Yan Director, Officer (CHIEF TECHNOLOGY OFFICER) | Shares withheld for tax | −1,346 | $4.67 | $6,286 |
| Aug 18, 2026 | William D. McCombe Officer (Chief Financial Officer) | Shares withheld for tax | −4,392 | $4.67 | $20,511 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.